Agomab Therapeutics NV

AGMB

$11.89▼ 0.92% 24h

Advanced chart & tools →

Agomab Therapeutics NVAGMB

$11.89

-$0.471(-3.81%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

$406.25M

P/E ratio

—

EPS (diluted)

—

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

—

Net margin

—

Gross margin

—

Dividends & financials

Agomab Therapeutics NV (AGMB) reported revenue of — and net income of —. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.